All In Biotech

Drug Trial Radar · NCT07664956

Cyclobenzaprine for Postoperative Pain in Minimally Invasive Hysterectomy

Cyclobenzaprine for Postoperative Pain in Minimally Invasive Hysterectomy: A Randomized Controlled Trial

Last checked: Nov 20, 2026Latest source record: Nov 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

36

Planned (sponsor's estimate)

Start

Sep 1, 2026

Primary completion

May 1, 2027

Study completion May 1, 2027

Sponsor

Lead sponsor
Christiana Care Health ServicesAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jun 24, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Typical postoperative pain control after minimally invasive hysterectomy includes ibuprofen, acetaminophen, and a short course of narcotics. The purpose of this study is to see if adding cyclobenzaprine to this regime improves pain control and lessens narcotic use.

Conditions

  • Minimally Invasive Surgical Procedures
  • Abnormal Uterine Bleeding, Unspecified
  • Adenomyosis of Uterus
  • Fibroid Uterus
  • Chronic Pelvic Pain
  • Endometriosis
  • Menorrhagia
  • Endometritis
  • Adnexal Diseases

Interventions

  • CyclobenzaprineDrug

    5mg cyclobenzaprine q8hr for one week postoperatively after minimally invasive hysterectomy

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Visual Analog Scale (VAS) Pain Score on Post Op Day 3Time frame: 3 days postoperatively

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • ChristianaCare Health System

    Newark, Delaware · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.